Substrate selectivity of the sublancin S-glycosyltransferase

Research output: Contribution to journalArticlepeer-review

Abstract

SunS is a novel S-glycosyltransferase involved in the biosynthesis of the antimicrobial peptide sublancin. It selectively modifies Cys22 in a 56 amino acid peptide substrate SunA and can accept a variety of NDP sugars. This study reports the substrate selectivity with regard to the peptide substrate and the antimicrobial activity of the resulting sublancin analogues. The results suggest that SunS recognizes an α-helix N-terminal of the Cys to be glycosylated, which is present in a flexible linker. Interestingly, when Cys22 is mutated, sugar attachment is not required for sublancin antimicrobial activity. Furthermore, the sublancin-producing strain Bacillus subtilis 168 also becomes susceptible to such mutants. These data suggest that S-glycosylation may be important for self-resistance.

Original languageEnglish (US)
Pages (from-to)16394-16397
Number of pages4
JournalJournal of the American Chemical Society
Volume133
Issue number41
DOIs
StatePublished - Oct 19 2011

ASJC Scopus subject areas

  • Catalysis
  • General Chemistry
  • Biochemistry
  • Colloid and Surface Chemistry

Fingerprint

Dive into the research topics of 'Substrate selectivity of the sublancin S-glycosyltransferase'. Together they form a unique fingerprint.

Cite this